Moreover, the change of the targeted lesion detected by CT or MRI showed that the tumor size decreased more significantly in patients who received ACT combined with anti-PD-1 compared with the sole treatment of ACT (Figures 3E, F). Here, PDCD1 is linked to neoplasm.